Search Results
687 results
Your search is now limited to «Company Strategy» expert search.
WN.com 01/16/2019 13:20
Luye Pharma Reaches Strategic Partnership with AstraZeneca, Strengthens Commitment to Cardiovascular Therapeutic Field Luye ... ......
More from WN.com:
Manufacturing Chemist 01/16/2019 11:30
Cancer drug push The acquisition of Loxo is Eli Lilly's biggest deal and it's aligned with the decision to focus on human pharmaceutical business.
More from Manufacturing Chemist:
FierceBiotech 01/16/2019 09:22
Roche has launched its uPath enterprise software for digital pathology, billing it as an improvement in speed and performance compared to its previous version known as Ventana Virtuoso.
More from FierceBiotech:
PR Newswire 01/16/2019 08:24
The J&J team has built a terrific business with a lot of positive momentum and a number of exciting growth opportunities for both J&J Driveaway and Auto Driveaway customer bases.
More from PR Newswire:
During the launch event, Merck Foundation also awarded Her Excellency to acknowledge her efforts as 'Merck More Than a Mother Ambassador in the country.
More from Middle East North Africa Financial Network (MENAFN):
FiercePharmaManufacturing 01/15/2019 09:58
RELATED: Bristol-Myers scores first big deal of 2019 with $74B buyout of oncology bigwig Celgene BMS and Celgene are unfazed by the criticism.
More from FiercePharmaManufacturing:
ENDPOINTS 01/14/2019 11:33
The FDA is giving Pfizer’s tafamidis a quick look over in advance of a likely approval.
More from ENDPOINTS:
Industrial Info 01/14/2019 02:11
GALWAY, IRELAND--January 14, 2018--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--GlaxoSmithKline (NYSE:GSK) (GSK) (Brentford, England) and Pfizer (NYSE:PFE) (New York, New York) have announced plans to merge their consumer healthcare divisions with combined sales of approximately £9.8 billion ($12.7 billion). Within this article: Details proposed merger, value, product lines affected, impact on manufacturing and jobs.
More from Industrial Info:
Zacks.com 01/11/2019 09:56
Shares of Amarin Corporation plc ( AMRN - Free Report) rallied 22.1% on Thursday, possibly on speculations that Pfizer ( PFE - Free Report) may bid to acquire the company.
More from Zacks.com:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications